Skip to main
AHR

AHR Stock Forecast & Price Target

AHR Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 23%
Buy 69%
Hold 8%
Sell 0%
Strong Sell 0%

Bulls say

American Healthcare REIT Inc. demonstrates a robust financial trajectory, highlighted by a rental rate growth of 4.1% year-over-year and exceptional same-store net operating income (NOI) growth, particularly within its Senior Housing Operating Portfolio (SHOP) at 25.3% and Integrated Senior Health Campus (ISHC) at 21.7%. The company has achieved the highest funds from operations (FFO) growth rate in the Healthcare REIT industry, supported by a favorable cost of capital and significant momentum in its investment initiatives. Additionally, with an anticipated two-year compound annual growth rate (CAGR) of 11.8% for Trilogy and 15.5% for SHOP, American Healthcare REIT is well-positioned to capitalize on organic growth opportunities and enhance its profitability.

Bears say

The analysis reveals a concerning trend for American Healthcare REIT Inc., highlighted by a reduction in leverage, with net debt to GAV decreasing to 28.8% as of 2Q25 from 38.7% in 3Q2024, suggesting improvements in debt management. However, a persistently high net debt to annualized EBITDA ratio of 3.7x indicates potential vulnerabilities in financial stability, particularly in light of economic headwinds and regulatory changes that could adversely affect tenant performance. Acquisition risks remain a significant challenge, as these factors could lead to diminished earnings expectations, exemplified by a projected $0.20/share earnings headwind due to declining Medicaid rates.

AHR has been analyzed by 13 analysts, with a consensus rating of Buy. 23% of analysts recommend a Strong Buy, 69% recommend Buy, 8% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About American Healthcare REIT Inc (AHR) Forecast

Analysts have given AHR a Buy based on their latest research and market trends.

According to 13 analysts, AHR has a Buy consensus rating as of Feb 4, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $50.54, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $50.54, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

American Healthcare REIT Inc (AHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.